Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 1, 2021
The Way of the Future: Personalizing Treatment Plans Through TechnologyMarte C Liefaard, Esther H Lips, Jelle Wesseling, et al.Communications Biology|September 12, 2019
Proteomic profiling of extracellular vesicles allows for human breast cancer subtypingStamatia Rontogianni, Eleni Synadaki, Bohui Li, et al.Iscience|May 24, 2024
Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsiesDonna O Debets, Erik L de Graaf, Marte C Liefaard, et al.Cell Reports. Medicine|October 5, 2023
Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2+ breast cancerDonna O Debets, Kelly E Stecker, Anastasia Piskopou, et al.Plos One|July 7, 2015
Vitamin D and C-Reactive Protein: A Mendelian Randomization StudyMarte C Liefaard, Symen Ligthart, Anna Vitezova, et al.British Journal of Cancer|February 10, 2023
Tumour-educated platelets for breast cancer detection: biological and technical insightsMarte C Liefaard, Kat S Moore, Lennart Mulder, et al.Breast (Edinburgh, Scotland)|August 3, 2022
Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survivalAnna van der Voort, Marte C Liefaard, Mette S van Ramshorst, et al.NPJ Breast Cancer|January 22, 2025
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionalityNoor A M Bakker, Hannah Garner, Ewald van Dyk, et al.Breast Cancer Research : BCR|July 2, 2025
A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancerCharlotta V Mulder, Elisabeth M Jongbloed, Marte C Liefaard, et al.Pageof 1